emiglitate has been researched along with Alloxan Diabetes in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bischoff, H | 1 |
| Bezerra, J; Bustamante, S; Flores, C; Goda, T; Koldovský, O; Lee, SM | 1 |
| Madar, Z; Olefsky, J | 1 |
1 review(s) available for emiglitate and Alloxan Diabetes
| Article | Year |
|---|---|
Pharmacology of alpha-glucosidase inhibition.
Topics: 1-Deoxynojirimycin; Acarbose; Animals; Blood Glucose; Carbohydrate Sequence; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diabetic Neuropathies; Dietary Carbohydrates; Digestion; Glucosamine; Glycation End Products, Advanced; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Molecular Sequence Data; Trisaccharides | 1994 |
2 other study(ies) available for emiglitate and Alloxan Diabetes
| Article | Year |
|---|---|
Chronic effects of an alpha-glucosidase inhibitor (Bay o 1248) on intestinal disaccharidase activity in normal and diabetic mice.
Topics: 1-Deoxynojirimycin; alpha-Glucosidases; Animals; beta-Galactosidase; Body Weight; Diabetes Mellitus, Experimental; Disaccharidases; Eating; Glucosamine; Glycoside Hydrolase Inhibitors; Intestine, Small; Mice; Mice, Inbred C57BL; Sucrase | 1987 |
Effect of the alpha-glucosidase inhibitor Bay-O-1248 on the metabolic response of nondiabetic and diabetic rats to a high-carbohydrate diet.
Topics: 1-Deoxynojirimycin; Animals; Blood Glucose; Body Weight; Cholesterol; Diabetes Mellitus, Experimental; Dietary Carbohydrates; Glucosamine; Glycosuria; Male; Rats; Rats, Inbred Strains; Triglycerides | 1986 |